Frontiers
US$ 27.59
retatrutide triple agonist gip glp-1 glucagon From Obesity to Metabolic Health: Why Is a Game-Changer Eli Lilly just announced striking
Description
PubMed Randomized trialTirzepatide evidence2024 Continued Treatment With Tirzepatide for Maintenance of Weight Reduction Used for continuation, stopping, and maintenance questions after initial weight loss
These effects are primarily indirect, mediated through weight reduction rather than direct action on lipid metabolism
Prior medication history matters
Precision medicine of obesity as an integral part of type 2 diabetes managementPast, present, and future
Any benefits from the supplement are generally subtle and accumulate gradually
Wieczorek, M
